Serum Anti-Helicobacter Pylori Lgg Antibodies and Pepsinogens A and C as Serological Markers of Chronic Atrophic Gastritis

Cancer Epidemiology Biomarkers and Prevention

Volumn 2, Issue 2, 1993, Pages 119-123

  Sitas, F ^a   Smallwood, R ^b   Jewell, D ^b   Millard, P R ^c   Newell, D G ^d   Meuwissen, S G M ^e   Moses, S ^c   Zwiers, A ^e   Forman, D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b Department of Gastroenterology ^*  (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; PEPSINOGEN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METAPLASIA; MICROBIOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STOMACH ANTRUM; STOMACH FUNDUS; STOMACH MUCOSA;

ADULT; AGED; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; FEMALE; GASTRIC FUNDUS; GASTRIC MUCOSA; GASTRITIS; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MALE; METAPLASIA; MIDDLE AGE; PEPSINOGENS; PYLORIC ANTRUM; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0027564187     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Strickland, R. G., and Mackay, I. R. A reappraisal of the nature and significance of chronic atrophic gastritis. Dig. Dis., 18: 426–440, 1973.
2. Price, A. B. The Sydney System: histological division. J. Gastroenterol. Hepatol., 6: 209–222, 1991.
3. Wyatt, J. I. Gastritis and its relation to gastric carcinogenesis. Semin. Diagn. Pathol., 8: 137–148, 1991.
4. Taylor, K. B. Gastritis. In: D. J. Weatherall, J. G. G. Ledingham, and D. Warrell (eds.), Oxford Textbook of Medicine, pp. 12.77–12.86. Oxford: Oxford University Press, 1987.
5. Villako, K., Ihamaki, T., Tamm, A., and Tammur, R. Upper abdominal complaints and gastritis. Ann. Clin. Res., 16: 192–194, 1984.
6. Whitehead, R. Mucosal biopsy of the gastrointestinal tract. In: J. L. Bennington (ed.), Major Problems in Pathology, pp. 36–50. London: W. Saunders Co., Ltd., 1973.
7. Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., and Rotter, J. I. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. A study of relatives of patients with pernicious anaemia. Gastroenterology, 83: 204–209, 1982.
8. Defize, J., and Meuwissen, S. G. M. Pepsinogens: an update of biochemical, physiological, and clinical aspects. J. Pediatr. Gastroentol. Nutr., 6:493–508, 1987.
9. Miki, K., Ichinose, M., Kawamura, N., Matsushima, M., Ahmed, H. B., et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn. J. Cancer Res., 80: 111–114, 1989.
10. Westerveld, B. D., Pals, G., Lamers, C. B., Defize, J., Pronk, J. C., et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer (Phila.), 59: 952–958, 1987.
11. Taylor, D. N. and Blaser, M. J. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev., 13: 42–59, 1991.
12. Smallwood, R. Is Campylobacter pylori a pathogen? In: D. P. Jewell and J. A. Snook (eds.), Topics in Gastroenterology 17, pp. 45–58. Oxford: Blackwell Scientific Publications, Ltd., 1990.
13. Newell, D. G., and Stacey, A. R. The serology of Campylobacter pylori infections. In: B. J. Rathbone and R. V. Heatley (eds.), Campylobacter pylori and Gastroduodenal Disease, pp. 74–82. Oxford: Blackwell, 1989.
14. Newell, D. G., Johnson, B. J., Ali, M. H., and Reed, P. I. An enzyme- linked immunosorbent assay for the serodiagnosis of Campylobacter pylori-associated gastritis. Scand. J. Gastroenterol., 23: 53–57, 1988.
15. Bancroft, J. D., and Stevens, A. Theory and Practice of Histological Techniques, Ed. 2. Edinburgh: Churchill Livingstone, 1982.
16. Talley, N. J., Newell, D. G., Ormand, J. E., Carpenter, H. E., Wilson, W. E., et al. Serodiagnosis of Helicobacter pylori: comparison of enzyme- linked immunosorbent assays. J. Clin. Microbiol., 29: 1635–1639, 1991.
17. Sackett, D. L., Haynes, R. B., and Tugwell, P. Clinical Epidemiology. A Basic Science for Clinical Medicine. Boston: Little, Brown and Company, 1985.
18. Armitage, P., and Berry, G. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, Ltd., 1987.
19. Fox, J. G., Correa, P., Taylor, N. S., Zavala, D., Fontham, E., et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am. J. Gastroenterol., 84: 775–781, 1989.
20. Correa, P., Fox, J., Fontham, E., Ruiz, B., Lin, Y., et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer (Phila.), 66: 2569–2574, 1990.
21. Miki, K., Ichinose, M., Shimizu, A., Huang, S. C., Oka, H., et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol. Jpn., 22: 133–141, 1987.
22. Correa, P., and Yardley, J. H. Grading and classification of chronic gastritis: one American response to the Sydney system. Gastroenterology, 102: 355–359, 1992.
23. Oderda, G., Vaira, D., Holton, J., Dowsett, J. F., and Ansaldi, N. Serum pepsinogen I and IgG antibody to Campylobacter pylori in nonspecific abdominal pain in childhood. Gut, 30: 912–916, 1989.
24. Asaka, M., Kimura, T., Kudo, M., Takeda, H., Mitani, S. et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology, 102: 760–766, 1992.